New Asiatic Pharmaceutical

Shanghai New Asiatic Pharmaceutical is a long-standing Chinese pharmaceutical manufacturer with a history dating back to 1926. As a core subsidiary of Shanghai Pharmaceuticals Holding (SPH), the company specializes in the development, production, and sale of anti-infective medications, particularly antibiotics. It is recognized as one of China's primary production bases for penicillin and streptomycin and operates multiple GMP-certified manufacturing facilities. The company's portfolio includes a wide range of dosage forms such as sterile powders for injection, tablets, and capsules. Beyond its domestic presence, New Asiatic Pharmaceutical maintains a significant export business, supplying essential medicines to international markets.